Telus, Faces

Telus Faces Historic Management Shake-Up as New Regulations and Heavy Debt Weigh on Shares

15.06.2026 - 01:42:36 | boerse-global.de

Telus undergoes historic dual CEO/CFO succession; stock down 7.5% YTD near 52-week low amid new Canadian telecom rules that ban activation fees, but debt reduction and insider buying signal potential.

Telus CEO & CFO Handover: Stock at Lows Amid New Telecom Rules
Telus - Telus Faces Historic Management Shake-Up as New Regulations and Heavy Debt Weigh on Shares 15.06.2026 - Bild: über boerse-global.de

All eyes are on Telus this week as the Canadian telecom giant prepares for an unprecedented dual succession at the top. Come July 1, both the chief executive and chief financial officer will hand over the reins simultaneously — a transition of this magnitude is a first for the company.

Darren Entwistle steps down after more than 20 years as president and CEO. His successor is Victor Dodig, who until 2025 led Canada’s major bank CIBC and has been a Telus board member since May 2022. Entwistle will stay on as CEO Emeritus and advisor until the end of April 2027 to ease the handover. On the financial side, Doug French retires after three decades with the company and is replaced by Gopi Chande, previously CFO of Telus Digital and Telus Health. French remains in an advisory role through July and will take the chairmanship of Telus subsidiary Terrion.

The new leadership team inherits a business that is far from broken but faces its own set of pressures. Telus generated a record free cash flow of C$2.2 billion in 2025 and has reaffirmed its target of roughly C$2.45 billion for 2026. Revenue and EBITDA growth are expected to run between 2% and 4% each. Management is also aiming to bring net debt-to-EBITDA down to about 3.3 times by year-end, from a current level of 3.5x. Yet adjusted net income remains under strain as the company continues pouring capital into health and artificial intelligence infrastructure.

Investors, however, have not rewarded the stock for that resilience. Telus shares last closed at C$16.64, a mere three percent above its 52-week low of C$16.18. The stock has fallen roughly 7.5% year-to-date and sits more than 22% below its October high of C$21.37. Technical indicators offer little reassurance: the relative strength index stands at 37.5, signalling persistent downward pressure, while both key moving averages now act as resistance.

Should investors sell immediately? Or is it worth buying Telus?

Adding to the headwinds, new Canadian telecom rules came into effect on June 12 that ban activation and early termination fees, making it easier for customers to switch providers. Reliable data on churn rates won’t be available until autumn, but the market is already discounting the uncertainty. The removal of switching barriers typically erodes pricing discipline among the big carriers, and Telus is squarely in the crosshairs.

Still, bulls point to real progress on the debt front. Capital expenditure is being trimmed to C$2.3 billion, and free cash flow is expected to climb toward C$2.5 billion, suggesting the peak of network investment has passed. Management is also exploring a sale or partnership for Telus Health, and a successful deal could act as a significant catalyst for the share price.

Insider activity sends a more optimistic signal. Under a new buyback program, Telus can repurchase up to 28 million shares for roughly C$500 million. Late last year, directors and executives scooped up more than 350,000 shares on the open market, buying near current lows. Such purchases are often interpreted as a vote of confidence in the company’s long-term valuation.

Telus at a turning point? This analysis reveals what investors need to know now.

The analyst community is split. Of 17 analysts covering the stock, seven rate it a buy, seven a hold, and three a sell. The average price target stands at C$20.28, implying upside of about 22% from the current price.

For the weeks ahead, the market will be watching closely for any signals from Dodig and Chande on strategic direction, particularly regarding capital allocation and debt reduction. A test of the 52-week low at C$16.18 remains a real possibility unless fresh news emerges on deleveraging or the Telus Health sale. The new duo takes the helm at a moment when the operational story is solid, but the macro and regulatory picture demands careful navigation.

Ad

Telus Stock: New Analysis - 15 June

Fresh Telus information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Telus analysis...

en | CA87971M1032 | TELUS | boerse | 69541211 |